Marker Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Marker Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Marker Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 8.9M shares, a 1.14% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.9M +100K +1.14% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 8.9M +100K +1.14% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 8.9M +100K +1.14% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 8.9M +500K +5.95% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 8.8M -74.8M -89.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 8.8M -74.8M -89.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 8.8M -74.7M -89.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 8.4M +100K +1.21% Dec 31, 2022 10-K 2024-03-26
Q3 2022 83.6M +500K +0.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 83.6M +500K +0.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 83.5M +500K +0.6% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 8.3M -42.4M -83.6% Dec 31, 2021 10-K 2023-03-22
Q3 2021 83.1M +35.1M +73.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 83.1M +36.5M +78.3% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 83M +36.5M +78.5% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 50.7M +5M +10.9% Dec 31, 2020 10-K 2022-03-17
Q3 2020 48M +2.3M +5.03% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 46.6M +1.1M +2.42% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 46.5M +1M +2.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 45.7M +300K +0.66% Dec 31, 2019 10-K 2021-03-09
Q3 2019 45.7M +31.9M +231% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 45.5M +31.9M +235% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 45.5M +34.9M +329% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 45.4M +34.8M +328% Dec 31, 2018 10-K 2020-03-12
Q3 2018 13.8M +3.3M +31.4% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 13.6M +3.44M +33.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 10.6M +2.13M +25.1% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 10.6M +2.2M +26.2% Dec 31, 2017 10-K 2019-03-15
Q3 2017 10.5M +2.1M +25.1% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 10.2M -61.3M -85.8% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 8.47M -62.5M -88.1% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 8.4M +2.52M +42.8% Dec 31, 2016 10-K 2018-03-23
Q3 2016 8.4M -54.5M -86.7% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 71.4M +33.4M +87.7% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 71M +38.4M +118% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 5.88M -14.4M -71% Dec 31, 2015 10-K 2017-03-14
Q3 2015 62.9M +43.3M +221% Sep 30, 2015 10-Q/A 2016-04-14
Q2 2015 38M +21.2M +126% Jun 30, 2015 10-Q/A 2016-04-14
Q1 2015 32.6M +16.8M +106% Mar 31, 2015 10-Q/A 2016-04-14
Q4 2014 20.3M +18.9M +1286% Dec 31, 2014 10-K 2016-04-14
Q3 2014 19.6M -125M -86.4% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 16.8M Jun 30, 2014 10-Q 2014-08-18
Q1 2014 15.8M -60.6M -79.3% Mar 31, 2014 10-Q/A 2014-05-21
Q4 2013 1.47M +702K +91.8% Dec 31, 2013 10-K 2015-04-15
Q3 2013 144M +70.4M +95.4% Sep 30, 2013 10-Q 2013-11-19
Q1 2013 76.4M +22.1M +40.6% Mar 31, 2013 10-Q 2013-08-19
Q4 2012 764K -51.3M -98.5% Dec 31, 2012 10-K/A 2014-04-17
Q3 2012 73.9M +26.5M +56% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 54.3M +7.52M +16.1% Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 54.3M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 52.1M +11.8M +29.4% Dec 31, 2011 10-K 2013-05-15
Q3 2011 47.4M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 46.8M Jun 30, 2011 10-Q 2011-08-22
Q4 2010 40.3M Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.